Advisory Services Network, LLC Dynavax Technologies Corp Transaction History

Advisory Services Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$13.09 - $14.98 $43,877 - $50,212	3,352 New	3,352 $46,000
Q1 2023 May 17, 2023	SELL	$9.44 - $11.88 $3,776 - $4,752	-400 Reduced 13.8%	2,499 $24,000
Q4 2022 Feb 13, 2023	BUY	$10.27 - $13.29 $29,772 - $38,527	2,899 New	2,899 $30,000
Q3 2021 Nov 05, 2021	SELL	$9.16 - $19.83 $28,854 - $62,464	-3,150 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.25 - $10.99 $22,837 - $34,618	3,150 New	3,150 $31,000
Q1 2021 May 24, 2021	SELL	$4.57 - $11.18 $14,395 - $35,217	-3,150 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.32 - $11.7 $13,608 - $36,855	3,150 New	3,150 $14,000

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.